1. A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial. Issue 1 (28th September 2019) Authors: Mease, Philip J; Smolen, Josef S; Behrens, Frank; Nash, Peter; Liu Leage, Soyi; Li, Lingnan; Tahir, Hasan; Gooderham, Melinda; Krishnan, Eswar; Liu-Seifert, Hong; Emery, Paul; Pillai, Sreekumar G; Helliwell, Philip S Journal: Annals of the rheumatic diseases Issue: Volume 79:Issue 1(2020) Page Start: 123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0741 ACHIEVEMENT OF CDAPSA LOW DISEASE ACTIVITY OR REMISSION IS ASSOCIATED WITH CONTROL OF ARTICULAR AND EXTRA-ARTICULAR MANIFESTATIONS OF ACTIVE PSORIATIC ARTHRITIS IN SUBJECTS TREATED WITH APREMILAST. (June 2019) Authors: Coates, Laura C.; Mease, Philip J.; Behrens, Frank; Orbai, Ana-Maria; Ogdie, Alexis; Brunori, Michele; Teng, Lichen; Guerette, Benoit; Smolen, Josef S. Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1835 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0773 PSORIATIC ARTHRITIS IMPACT OF DISEASE QUESTIONNAIRE SCORES ARE CORRELATED WITH DISEASE ACTIVITY, AS MEASURED BY CDAPSA, IN PATIENTS WITH PSORIATIC ARTHRITIS. (June 2019) Authors: Orbai, Ana-Maria; Krueger, Klaus; Behrens, Frank; Kiltz, Uta; Guerette, Benoit; Mellars, Lillian; Brunori, Michele; Wollenhaupt, Jurgen Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0786 HIGH TREATMENT SATISFACTION OF THERAPY WITH USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS DUE TO EARLY AND LONG-TERM TREATMENT RESPONSE AND HIGH TOLERABILITY – RESULTS OF THE NON-INTERVENTIONAL STUDY SUSTAIN. (June 2019) Authors: Wendler, Joerg; Wagener, Peter; Hamann, Frank; Damann, Nils; Movshovich, Evgenia; Behrens, Frank Journal: Annals of the rheumatic diseases Issue: Volume 78(2019)Supplement 2 Page Start: 1862 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid Arthritis. Issue 11 (1st October 2016) Authors: Scharbatke, Eva C.; Behrens, Frank; Schmalzing, Marc; Koehm, Michaela; Greger, Gerd; Gnann, Holger; Burkhardt, Harald; Tony, Hans‐Peter Journal: Arthritis care & research Issue: Volume 68:Issue 11(2016:Nov.) Page Start: 1607 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE). Issue 10370 (7th January 2023) Authors: Merola, Joseph F; Landewé, Robert; McInnes, Iain B; Mease, Philip J; Ritchlin, Christopher T; Tanaka, Yoshiya; Asahina, Akihiko; Behrens, Frank; Gladman, Dafna D; Gossec, Laure; Gottlieb, Alice B; Thaçi, Diamant; Warren, Richard B; Ink, Barbara; Assudani, Deepak; Bajracharya, Rajan; Shende, Vishv... Journal: Lancet Issue: Volume 401:Issue 10370(2023) Page Start: 38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial. Issue 8 (13th May 2020) Authors: Kedor, Claudia; Listing, Joachim; Zernicke, Jan; Weiß, Anja; Behrens, Frank; Blank, Norbert; Henes, Joerg Christoph; Kekow, Joern; Rubbert-Roth, Andrea; Schulze-Koops, Hendrik; Seipelt, Eva; Specker, Christof; Feist, Eugen Journal: Annals of the rheumatic diseases Issue: Volume 79:Issue 8(2020) Page Start: 1090 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study. (April 2022) Authors: Coates, Laura C; Tillett, William; D'Agostino, Maria-Antonietta; Rahman, Proton; Behrens, Frank; McDearmon-Blondell, Erin L; Bu, Xianwei; Chen, Liang; Kapoor, Mudra; Conaghan, Philip G; Mease, Philip Journal: Lancet Issue: Volume 4:Number 4(2022) Page Start: e262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA. Issue 1 (10th March 2023) Authors: Regierer, Anne Constanze; Weiß, Anja; Proft, Fabian; Baraliakos, Xenofon; Behrens, Frank; Poddubnyy, Denis; Schett, Georg; Lorenz, Hanns-Martin; Worsch, Matthias; Strangfeld, Anja Journal: RMD open Issue: Volume 9:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Development and Validation of a New Disease Activity Score in 28 Joints–Based Treatment Response Criterion for Rheumatoid Arthritis. Issue 10 (24th September 2013) Authors: Behrens, Frank; Tony, Hans‐Peter; Alten, Rieke; Kleinert, Stefan; Scharbatke, Eva C.; Köhm, Michaela; Gnann, Holger; Tams, Johanna; Greger, Gerd; Burkhardt, Harald Journal: Arthritis care & research Issue: Volume 65:Issue 10(2013:Oct.) Page Start: 1608 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗